AS
IRWD icon

Altshuler Shaham’s Ironwood Pharmaceuticals IRWD Stock Holding History

Altshuler Shaham’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,639
Closed -$65K – 498
2022
Q2 		$65K Buy
+5,639
New +$66.4K ﹤0.01% 206
2020
Q3 		– Sell
-1,950
Closed -$20K – 407
2020
Q2 		$20K Buy
1,950
+820
+73% +$8.39K ﹤0.01% 261
2020
Q1 		$11K Buy
+1,130
New +$13.3K ﹤0.01% 287

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Altshuler Shaham's IRWD Position: Q3 2022 in Review

Altshuler Shaham sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2022, closing a stake of 5,639 shares — an estimated $65K sold.

Altshuler Shaham first reported a position in IRWD in Q1 2020 and held it in 3 quarters. The position peaked at $65K in Q2 2022. 245 funds tracked by Wall St. Rank hold IRWD as of Q3 2022.

  • Altshuler Shaham reported no remaining Ironwood Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Altshuler Shaham sold 5,639 Ironwood Pharmaceuticals shares in Q3 2022, an estimated $65K.
  • Altshuler Shaham first reported a position in Ironwood Pharmaceuticals in Q1 2020 and held it in 3 quarters.
  • Altshuler Shaham's Ironwood Pharmaceuticals position peaked at $65K in Q2 2022.
  • 245 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2022.

Based on Altshuler Shaham's 13F filing for Q3 2022, filed 14 Nov 2022.